Skip to content

Wave Life Sciences WVE Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Liquidity
Current ratio11.3×+4.8×6.5×+4.0×2.5×0.0×2.6×-0.4×+0.1×
Leverage
Debt-to-equity0.0×-0.1×0.2×0.0×0.2×
Per Share
Book value per share$2.56-16.8%$3.07+314%$0.74-12.6%$0.85-19.6%$1.06-30.3%
Valuation
Market capitalization$1.14B+13.0%$3.16B+171%$1.17B+9.7%$1.06B-14.3%$1.24B-34.3%
Price / book2.2×-3.7×6.1×-3.3×9.4×+1.7×7.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Wave Life Sciences's ratios come from?
Every ratio is computed from Wave Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.